Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.887354
Abstract: Sjögren’s syndrome (SS) is a systemic autoimmune disease with no efficient treatment, and it is associated with dysregulated immune cells and impaired interleukin (IL)-2 signaling. IL-2 is critical for the development and maintenance of Treg… read more here.
Keywords: dose interleukin; gren syndrome; syndrome murine; ameliorates gren ... See more keywords